Natco Pharma Limited has informed the Exchange about Schedule of Earnings Call with Investors / Analysts at on Thursday, the 29th May 2025 at 11:00 AM IST to discuss the Audited Financial Results of the Company for the quarter and year ended 31st March, 2025
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natco Pharma has scheduled an earnings call with investors and analysts on Thursday, May 29, 2025, at 11:00 AM IST to discuss its audited financial results for the quarter and full year ended March 31, 2025. The call will be hosted by Batlivala & Karani Securities India Pvt. Ltd. Vice-Chairman and CEO Mr. Rajeev Nannapaneni and Executive Vice President Mr. Rajesh Chebiyam will represent the company's management. Dial-in numbers for participants across India and international locations have been provided, along with a Diamond Pass registration link for easier access.
This is a routine investor relations communication and is not expected to have a direct impact on the stock price. Investors and analysts will look out for any guidance or commentary shared during the call on May 29, which could influence sentiment post the event.